Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction

• URL: http://arxiv.org/abs/2306.05257v1
• Date: Thu, 8 Jun 2023 14:54:50 GMT
• Title: Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction
• Authors: Xuan Lin, Lichang Dai, Yafang Zhou, Zu-Guo Yu, Wen Zhang, Jian-Yu Shi, Dong-Sheng Cao, Li Zeng, Haowen Chen, Bosheng Song, Philip S. Yu and Xiangxiang Zeng
• Abstract summary: Recent advances in artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications. DDIs refer to a change in the effect of one drug to the presence of another drug in the human body. To correctly apply the advanced AI and deep learning, the developer and user meet various challenges such as the availability and encoding of data resources.
• Score: 43.5957881547028
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Recent advances and achievements of artificial intelligence (AI) as well as deep and graph learning models have established their usefulness in biomedical applications, especially in drug-drug interactions (DDIs). DDIs refer to a change in the effect of one drug to the presence of another drug in the human body, which plays an essential role in drug discovery and clinical research. DDIs prediction through traditional clinical trials and experiments is an expensive and time-consuming process. To correctly apply the advanced AI and deep learning, the developer and user meet various challenges such as the availability and encoding of data resources, and the design of computational methods. This review summarizes chemical structure based, network based, NLP based and hybrid methods, providing an updated and accessible guide to the broad researchers and development community with different domain knowledge. We introduce widely-used molecular representation and describe the theoretical frameworks of graph neural network models for representing molecular structures. We present the advantages and disadvantages of deep and graph learning methods by performing comparative experiments. We discuss the potential technical challenges and highlight future directions of deep and graph learning models for accelerating DDIs prediction.

Related papers

• Benchmarking Graph Learning for Drug-Drug Interaction Prediction [30.712106722531313]
  Predicting drug-drug interaction (DDI) plays an important role in pharmacology and healthcare. Recent graph learning methods have been introduced to predict drug-drug interactions. We propose a DDI prediction benchmark on graph learning.
  arXiv  Detail & Related papers  (2024-10-24T09:35:34Z)
• A Survey of Models for Cognitive Diagnosis: New Developments and Future Directions [66.40362209055023]
  This paper aims to provide a survey of current models for cognitive diagnosis, with more attention on new developments using machine learning-based methods. By comparing the model structures, parameter estimation algorithms, model evaluation methods and applications, we provide a relatively comprehensive review of the recent trends in cognitive diagnosis models.
  arXiv  Detail & Related papers  (2024-07-07T18:02:00Z)
• Simplicity within biological complexity [0.0]
  We survey the literature and argue for the development of a comprehensive framework for embedding of multi-scale molecular network data. Network embedding methods map nodes to points in low-dimensional space, so that proximity in the learned space reflects the network's topology-function relationships. We propose to develop a general, comprehensive embedding framework for multi-omic network data, from models to efficient and scalable software implementation.
  arXiv  Detail & Related papers  (2024-05-15T13:32:45Z)
• Discovering intrinsic multi-compartment pharmacometric models using Physics Informed Neural Networks [0.0]
  We introduce PKINNs, a novel purely data-driven neural network model. PKINNs efficiently discovers and models intrinsic multi-compartment-based pharmacometric structures. The resulting models are both interpretable and explainable through Symbolic Regression methods.
  arXiv  Detail & Related papers  (2024-04-30T19:31:31Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• CADGL: Context-Aware Deep Graph Learning for Predicting Drug-Drug Interactions [5.648318448953635]
  Examining Drug-Drug Interactions (DDIs) is a pivotal element in the process of drug development. We aim to address challenges by leveraging the effectiveness of context-aware deep graph learning by introducing a novel framework named CADGL. Based on a customized variational graph autoencoder (VGAE), we capture critical structural and physio-chemical information. We excel in predicting clinically valuable novel DDIs, supported by rigorous case studies.
  arXiv  Detail & Related papers  (2024-03-25T21:37:31Z)
• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• Knowledge-augmented Graph Machine Learning for Drug Discovery: A Survey [6.288056740658763]
  Graph Machine Learning (GML) has gained considerable attention for its exceptional ability to model graph-structured biomedical data. Recent studies have proposed integrating external biomedical knowledge into the GML pipeline to realise more precise and interpretable drug discovery.
  arXiv  Detail & Related papers  (2023-02-16T12:38:01Z)
• ImDrug: A Benchmark for Deep Imbalanced Learning in AI-aided Drug Discovery [79.08833067391093]
  Real-world pharmaceutical datasets often exhibit highly imbalanced distribution. We introduce ImDrug, a benchmark with an open-source Python library which consists of 4 imbalance settings, 11 AI-ready datasets, 54 learning tasks and 16 baseline algorithms tailored for imbalanced learning. It provides an accessible and customizable testbed for problems and solutions spanning a broad spectrum of the drug discovery pipeline.
  arXiv  Detail & Related papers  (2022-09-16T13:35:57Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.